James Edgemond

James Edgemond

Chief Financial Officer and TreasureratUnited Therapeutics· In proxies 2021–2025

Pay in FY2025-9% from the year before · United Therapeutics stock +38.1% the same year

James Edgemond was paid $8.3M in FY2025 (Dec), down 9%. United Therapeutics stock rose 38.1% that year.

Pay$100 in the stock at the end of FY20 → $321
Pay is from the Summary Compensation Table of each United Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. United TherapeuticsPublic company · 5 yr
    • Chief Financial Officer and Treasurer2021 – Present · 5 yrStock in role +291%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?